Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control armsMehmet Burcu, Wei Zhou, Nancy A Dreyer et al.|Pharmacoepidemiology and Drug Safety|2020Cited by 120
Pim-1 Kinase Protects P-Glycoprotein from Degradation and Enables Its Glycosylation and Cell Surface ExpressionYingqiu Xie, Maria R. Baer, Yun Qiu et al.|Molecular Pharmacology|2010Cited by 95
The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanismsKarthika Natarajan, Maria R. Baer, Jasjeet Bhullar et al.|Biochemical Pharmacology|2012Cited by 91
Pim-1 Kinase Phosphorylates and Stabilizes 130 kDa FLT3 and Promotes Aberrant STAT5 Signaling in Acute Myeloid Leukemia with FLT3 Internal Tandem DuplicationKarthika Natarajan, Maria R. Baer, Yingqiu Xie et al.|PLoS ONE|2013Cited by 74